VACUUM THERAPY IN THE UPPER GASTROINTESTINAL TRACT
VacStent GI™
Innovative treatment of anastomotic leakage and perforations in the esophagus, stomach and duodenum.
VacStent GI™
Ref: 00003820
Ø tulip: 28 mm
Ø stent: 14 mm
Total length: 70 mm
Sponge length: 50 mm
VacStent GI™ (XL variant)
Ref: 00004229
Ø tulip: 25 mm
Ø stent: 12 mm
Total length: 120 mm
Sponge length: 100 mm
A synergy of the best features of well-established treatment methods.
This smart combination offers decisive advantages: In the upper gastrointestinal tract, the stent maintains luminal patency, allowing patients to be nourished orally in many cases—without the need for tube feeding or intravenous fluid administration.
In addition, access for medical instruments is maintained after placement, offering greater flexibility in follow-up care. Vacuum therapy also effectively prevents dislocation of the stent, even in the presence of strong peristalsis, ensuring high positional stability throughout treatment.
Indications
1. Treatment of anastomotic leakage, perforations and other defects
Read more
The VacStent GI™ is ideally suited for the treatment of endoscopically accessible anastomotic leakage and perforations in the esophagus, stomach and duodenum. The innovative combination of vacuum therapy and stent-based sealing ensures effective drainage and reliable closure of the affected areas.
2. Prophylactic use during surgery
Read more
The VacStent GI™ can be used prophylactically during surgical procedures to reduce the risk of anastomotic leakage. This may promote faster healing and contribute to a reduction in postoperative complications.
Clinical case studies
Small abscess at the circular staple suture 14 days after subtotal esophagectomy with intrathoracic anastomosis.
Chest CT shows the exact location of the VacStent GI™ and no signs of mediastinitis or abscess formation.
Condition of the staple line leak after five days of treatment.
A shallow wound cavity entirely covered by granulation tissue.
Treatment of anastomotic leakage after subtotal esophagectomy
This case report describes the successful treatment of anastomotic leakage following subtotal esophagectomy with the innovative use of a VacStent GI™, which reliably sealed the insufficiency and effectively supported wound healing through continuous negative pressure. Follow-up examinations confirmed a complete and complication-free recovery.
Perforation from 40-42 cm in the distal esophagus after pneumatic dilatation.
Perforation from 40-42 cm in the distal esophagus after pneumatic dilatation.
VacStent GITM deployed in the esophagus.
Healed defect due to VacStent GITM treatment.
Treatment of an iatrogenic defect after pneumodilation
CT image of a large perigastric abscess with visible air bubbles after placement of the first self-expanding metal stent (before treatment with VacStent GITM).
CT image showing complete resolution of the perigastric abscess following treatment with VacStent GITM.
Treatment of leakage after bariatric surgery
In this case report, a 30-year-old female patient presented with a 30 mm vertical suture leak following laparoscopic sleeve gastrectomy. After a covered SEMS stent failed due to migration, a VacStent GI™ was placed, resulting in complete healing of the defect.
Preventive use of the VacStent GI™ for high-risk anastomosis
In a pilot study, the VacStent GI™ was used preemptively in nine patients at high risk of anastomotic leakage following neoadjuvant therapy and Ivor-Lewis hybrid esophagectomy. The procedure was technically successful in all cases, with no postoperative mortality or septic complications. Only one patient developed an anastomotic leak, which was successfully treated with the VacStent GI™.
The VacStent GI™ combines the best features of esophageal stenting and endoscopic vacuum therapy, providing adequate closure and drainage, while the patient is able to drink and eat. I am very impressed by the results I have seen in patients with anastomotic leakage and other types of esophageal perforation.
The VacStent GI™ was the greatest technical innovation in endoscopic vacuum therapy products in the last decade. The homogenous application of negative pressure on the defect without occlusion of the lumen makes it an ideal device for endoluminal application.
Phenomenal early results with gross mediastinal and thoracic contamination, huge benefits to this unfortunate group of patients with oesophageal rupture.
Do you have any questions about the VacStent GI™?
If you would like to find out more about our innovative product, the VacStent GI™, we will be happy to help you. Do not hesitate to contact us – we will be happy to answer your questions and provide you with detailed advice.